Replay available

Eisai Co Ltd (ESALF) Q4 2025 Earnings Call

Eisai Co Ltd (OTC: ESALF) Q4 2025 earnings conference call, held 2025-05-15. Replay captured from the company's public earnings webcast.

Thu, May 15, 2025 at 2:30 AMendedReplay
Eisai Co Ltd (ESALF) Q4 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Haruo Naito

Representative Corporate Officer and CEO

Mr. Ike

Executive Vice President & CFO

Tsutsumu Shimoyama

Non-fiction Writer

Tsutomu Banno

Journalist, Nikkei

Tony Lin

Analyst, Macaulay Securities

Replay transcript excerpt

Thank you very much for taking your time to attend the financial results briefing session by ASI. It is now time we would like to begin the briefing session by ASI Company Limited on financial results and business update for fiscal 2024. Those of you who are in attendance in person, please find materials including a deck of presentation and flash report. Those of you who are virtually attending, please find these materials on the website. Let me introduce the speaker, Mr. Haruo Naito, Representative Corporate Officer and CEO. Now, we would like to report on the financial results for fiscal year 2024. First, let us share with you the P&L for FY2024. Revenue and profit both, while we continue to invest resources into Kenbi, have achieved an increase in both revenue and profits. As we have already announced, the forecast for FY2024, but both revenue and profits exceeded that forecast. If you look at this table, cost of sales increased by 0.5% each point. This is due to what is described above, other business or one-time decrease of revenue, which increased the cost of sales ratio. And if you turn to the expense side, R&D expenses accounted for the ratio, which was reduced by 1.6 percentage points in terms of its ratio to the revenue, mainly in the United States, research laboratories outside of Japan. There are some inactive research laboratories or obsolete research laboratories were decided to be closed, but among the themes of research were dropped with some impairment losses. Absorbing those, R&D expense ratio to revenue was reduced by 1.0 percentage points, and SG&A expenses increased by 1.2 percentage points. Because we continue to invest resources into that can be particularly marketing resources were invested in this SG&A expenses in which includes expenses rela...

More from Eisai Co., Ltd.